All Companies

TNDMCongressional Stock Trades

Tandem Diabetes Care, Inc.

Surgical & Medical Instruments & Apparatus

Congressional stock trades in Tandem Diabetes Care, Inc. (TNDM) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

4

Politicians Trading

2

Last Traded

Sep 29, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Gilbert Ray Cisneros, Jr.DOct 12, 2026Sep 29, 2026Buy$1,001 - $15,000+12.67%
Josh GottheimerDOct 15, 2025Sep 22, 2025Buy$1,001 - $15,000+42.96%
Josh GottheimerDApr 10, 2025Mar 19, 2025Sell$1,001 - $15,000-9.46%
Gilbert Ray Cisneros, Jr.DApr 7, 2025Mar 4, 2025Buy$1,001 - $15,000-4.21%

Price History

About Tandem Diabetes Care, Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.

FAQ

2 members of Congress have disclosed 4 trades in Tandem Diabetes Care, Inc. (TNDM). Most active: Gilbert Ray Cisneros, Jr. (2), Josh Gottheimer (2).

Across all disclosures, members of Congress reported 3 purchases and 1 sales of Tandem Diabetes Care, Inc. (TNDM). The most recent trade was on Sep 29, 2026.

Gilbert Ray Cisneros, Jr. disclosed buying Tandem Diabetes Care, Inc. (TNDM) on Sep 29, 2026, valued at $1,001 - $15,000.

Josh Gottheimer disclosed selling Tandem Diabetes Care, Inc. (TNDM) on Mar 19, 2025, valued at $1,001 - $15,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.